Principal Financial Group Inc. Has $11.05 Million Holdings in Azenta, Inc. (NASDAQ:AZTA)

Principal Financial Group Inc. lifted its holdings in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 94.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 221,083 shares of the company's stock after acquiring an additional 107,339 shares during the quarter. Principal Financial Group Inc. owned approximately 0.48% of Azenta worth $11,054,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in AZTA. Farther Finance Advisors LLC boosted its holdings in shares of Azenta by 20.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company's stock worth $74,000 after buying an additional 256 shares during the period. QRG Capital Management Inc. boosted its holdings in shares of Azenta by 6.6% during the third quarter. QRG Capital Management Inc. now owns 6,156 shares of the company's stock worth $298,000 after acquiring an additional 383 shares during the period. Ballentine Partners LLC grew its position in shares of Azenta by 2.0% in the fourth quarter. Ballentine Partners LLC now owns 20,340 shares of the company's stock valued at $1,017,000 after purchasing an additional 404 shares during the last quarter. Glenmede Trust Co. NA increased its stake in shares of Azenta by 6.3% during the third quarter. Glenmede Trust Co. NA now owns 11,379 shares of the company's stock worth $551,000 after purchasing an additional 679 shares during the period. Finally, KBC Group NV lifted its holdings in Azenta by 48.5% during the 4th quarter. KBC Group NV now owns 2,137 shares of the company's stock worth $107,000 after purchasing an additional 698 shares during the last quarter. Institutional investors own 99.08% of the company's stock.

Wall Street Analysts Forecast Growth

AZTA has been the topic of several recent research reports. Evercore ISI increased their price objective on Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a research report on Thursday, February 6th. Needham & Company LLC lifted their price objective on shares of Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a research note on Thursday, February 6th. TD Cowen upgraded shares of Azenta to a "hold" rating in a research report on Thursday, February 27th. Finally, Stephens reiterated an "overweight" rating and issued a $60.00 price target on shares of Azenta in a research report on Thursday, January 2nd. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, Azenta currently has an average rating of "Hold" and a consensus price target of $58.75.

Azenta Stock Down 1.7 %

Shares of NASDAQ:AZTA traded down $0.71 during midday trading on Tuesday, hitting $40.40. The stock had a trading volume of 435,920 shares, compared to its average volume of 512,628. The company's 50-day moving average price is $49.99 and its 200-day moving average price is $47.61. Azenta, Inc. has a fifty-two week low of $38.82 and a fifty-two week high of $67.77. The company has a market capitalization of $1.85 billion, a P/E ratio of -13.52 and a beta of 1.47.

Azenta (NASDAQ:AZTA - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, beating the consensus estimate of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. Research analysts expect that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.